MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

PF-5274857

CAS No. : 1373615-35-0

MCE 站：PF-5274857

产品活性：PF-5274857 是一种有效的、选择性的、具有口服活性和可透过血脑屏障的 Smo 拮抗剂，IC₅₀ 值为 5.8 nM，K_i 值为 4.6 nM。PF-5274857 有潜力用于包括激活的 Hh 途径驱动的脑肿瘤和脑转移在内的多种肿瘤的研究。

研究领域：Stem Cell/Wnt

作用靶点：Smo

In Vitro: PF-5274857 completely inhibits Shh-induced Hh pathway activity with an IC₅₀ of 2.7±1.4 nM measured by the transcriptional activity of Smo downstream gene Gli1 in MEF cells.
PF-5274857 shows less than 20% inhibition against a broad panel of protein kinases at 1 μM.

In Vivo: PF-5274857 (1-30 mg/kg; p.o. once daily for 6 days) shows robust antitumor efficacy and correlation between PK and PD in medulloblastoma allograft mice models.
PF-5274857 (10 mg/kg; i.h.) in the plasma is able to cross the blood-brain barrier in rats within 4 hours postdose.
PF-5274857 (10-100 mg/kg; p.o. once daily for 4 days) is able to target Smo in the brain leading to the downregulation of Hh pathway activity in the brain tumor.
PF-5274857 (30 mg/kg; p.o. once daily for 34 days) increases the survival rates of primary Ptch^+/? p53^?/? medulloblastoma mice.
PF-5274857 (5-30 mg/kg; p.o.) exhibits the apparent volume of distribution of 5.6±0.5 L/kg and the half-life (T_1/2) of 1.7±0.1 hours.

相关产品：Bioactive Compound Library Plus  |  Stem Cell Signaling Compound Library  |  Wnt/Hedgehog/Notch Compound Library  |  Anti-Cancer Compound Library  |  CNS-Penetrant Compound Library  |  Anti-Aging Compound Library  |  Orally Active Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Cyclopamine  |  SAG  |  Purmorphamine  |  20(S)-Hydroxycholesterol  |  Halcinonide  |  Jervine  |  ALLO-2  |  IHR-Cy3

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。